Pre-Exercise Cardiology Screening Guidelines for Asymptomatic Patients with Diabetes

Clinics in Sports Medicine

Volumn 28, Issue 3, 2009, Pages 379-392

  Angadi, Siddhartha S ^a   Gaesser, Glenn A ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Asymptomatic; Cardiovascular disease risk; Diabetes; Exercise; Screening; Silent myocardial ischemia

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ALGORITHM; ANGIOCARDIOGRAPHY; ARTERY DISEASE; AUTONOMIC NEUROPATHY; CARDIOLOGY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVASCULAR ULTRASOUND; LABORATORY TEST; LIFESTYLE MODIFICATION; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT IDENTIFICATION; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYMPTOMATOLOGY; TREATMENT INDICATION;

ADULT; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC TESTS, ROUTINE; EARLY DIAGNOSIS; EXERCISE; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; UNITED STATES;

EID: 66349091018     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2009.02.002     Document Type: Review

References (77)

1. Blendea M.C., McFarlane S.I., Isenovic E.R., et al. Heart disease in diabetic patients. Curr Diab Rep 3 (2003) 223-229
2. Bonow R.O., Bohannon N., and Hazzard W. Risk stratification in coronary artery disease and special populations. [review]. Am J Med 101 (1996) 17S-22S
3. Dorman J.S., Laporte R.E., Kuller L.H., et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33 (1984) 271-276
4. Laing S.P., Swerdlow A.J., Slater S.D., et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46 (2003) 760-765
5. Moss S.E., Klein R., and Klein B.E. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81 (1991) 1158-1162
6. Church T.S., LaMonte M.J., Barlow C.E., et al. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 165 (2005) 2114-2120
7. Wing R.R., Jakicic J., Neiberg R., et al. Fitness, fatness, and cardiovascular risk factors in type 2 diabetes: look ahead study. Med Sci Sports Exerc 39 (2007) 2107-2116
8. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 25 (2002) S64-S68
9. Sigal R.J., Kenny G.P., Wasserman D.H., et al. Physical activity/exercise and type 2 diabetes. A consensus statement from the American Diabetes Association. Diabetes Care 29 (2006) 1433-1438
10. Bax J.J., Bonow R.O., Tschope D., et al., on behalf of the Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48 (2006) 754-760
11. Miller T.D., Redberg R.F., and Wackers F.J.T. Screening asymptomatic diabetic patients for coronary artery disease. Why not?. J Am Coll Cardiol 48 (2006) 761-764
12. Bax J.J., Young L.H., Frye R.L., et al. Screening for coronary artery disease in patients with diabetes. Diabetes Care 30 (2007) 2729-2736
13. Multiple Risk Factor Intervention Trial Research Group. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 55 (1985) 16-24
14. Rutter M.K., Wahid S.T., McComb J.M., et al. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 40 (2002) 56-61
15. Fornengo P., Bosio A., Epifani G., et al. Prevalence of silent myocardial ischemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabetes Med 23 (2006) 775-779
16. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961
17. Janand-Delenne B., Savin B., Habib G., et al. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22 (1999) 1396-1400
18. BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96 (1997) 1761-1769
19. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
20. Larsen J., Brekke M., Sandvik L., et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51 (2002) 2637-2641
21. Wackers F.J., Chyun D.A., Young L.H., et al., Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 30 (2007) 2892-2898
22. Faglia E., Manuela M., Antonella Q., et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149 (2005) e1-e6
23. Sorajja P., Chareonthaitawee P., Rajagopalan N., et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation 112 9 Suppl (2005) I311-I316
24. Kohl H.W., Powell K.E., Gordon N.F., et al. Physical activity, physical fitness, and sudden cardiac death. Epidemiol Rev 14 (1992) 37-57
25. Paterson D.J. Antiarrhythmic mechanisms during exercise. J Appl Physiol 80 (1996) 1853-1862
26. Willich S.N., Maclure M., Mittleman M., et al. Sudden cardiac death: support for a role of triggering in causation. Circulation 87 (1993) 1442-1450
27. Sexton P.T., Walsh J., Jamrozik K., et al. Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust N Z J Med 27 (1997) 45-50
28. Lemaitre R.N., Siscovick D.S., Raghunathan T.E., et al. Leisure-time physical activity and the risk of primary cardiac arrest. Arch Intern Med 159 (1999) 686-690
29. Erbs S., Linke A., and Hambrecht R. Effects of exercise training on mortality in patients with coronary heart disease. Coron Artery Dis 17 (2006) 219-225
30. Hambrecht R., Walther C., Möbius-Winkler S., et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 109 (2004) 1371-1378
31. Kendziorra K., Walther C., Foerster M., et al. Changes in myocardial perfusion due to physical exercise in patients with stable coronary artery disease. Eur J Nucl Med Mol Imaging 32 (2005) 813-819
32. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21 (1998) 1551-1559
33. Rajagopalan N., Miller T.D., Hodge D.O., et al. Identifying high risk asymptomatic diabetic patients who are candidates for screening stress single photon emission computed tomography imaging. J Am Coll Cardiol 45 (2005) 43-49
34. Scognamiglio R., Negut C., Ramondo A., et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47 (2006) 65-71
35. De Lorenzo A., Lima R.S., Siqueira-Filho A.G., et al. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90 8 (2002) 827-832
36. Giri S., Shaw L.J., Murthy D.R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 1 (2002) 32-40
37. Sultan A., Piot C., Mariano-Goulart D., et al. Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients. Diabetes Care 27 7 (2004) 1745-1757
38. Akasaka T., Yoshida K., Hozumi T., et al. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 30 (1997) 935-941
39. Abbott R.D., Donahue R.P., Kannel W.B., et al. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 260 (1988) 3456-3460
40. Kloner R.A. Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient. J Am Coll Cardiol 51 (2008) 2051-2052
41. Ma R.C., So W.Y., Yang X., et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 51 21 (2008) 2045-2050
42. Ward R.C., Weiner J., Taillon L.A., et al. Comparison of findings on stress myocardial perfusion imaging in men with versus without erectile dysfunction and without prior heart disease. Am J Cardiol 101 4 (2008) 502-505
43. Rutter M.K., McComb J.M., Brady S., et al. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 83 1 (1999) 27-31
44. Papaioannou G.I., Seip R.L., Grey N.J., et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 94 3 (2004) 294-299
45. Mann J.F., Gerstein H.C., Pogue J., et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
46. Araz M., Celen Z., Akdemir I., et al. Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control. Acta Diabetol 41 2 (2004) 38-43
47. Milan Study on Atherosclerosis and Diabetes (MISAD Group). Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non-insulin dependent diabetes mellitus. Am J Cardiol 79 (1997) 134-139
48. Naka M., Hiramatsu K., Aizawa T., et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 123 1 (1992) 46-53
49. Earle K.A., Mishra M., Morocutti A., et al. Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 39 (1996) 854-856
50. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
51. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48 (1999) 937-942
52. Doobay A.V., and Anand S.S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 25 7 (2005) 1463-1469
53. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344 (2001) 1608-1621
54. Baxter C.G., Boon N.A., and Walker J.D. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 28 3 (2005) 756-757
55. MiSAD investigators. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol 79 2 (1997) 134-139
56. Do D., West J.A., Morise A., et al. A consensus approach to diagnosing coronary artery disease based on clinical and exercise test data. Chest 111 (1997) 1742-1749
57. American College of Sports Medicine. Guidelines for exercise testing and prescription. 7th edition (2006), Lippincott Williams & Wilkins, Baltimore (MD) p. 19-35
58. Harris G.D., and White R.D. Exercise stress testing in patients with type 2 diabetes: when are asymptomatic patients screened?. Clin Diabetes 25 (2007) 126-130
59. Nesto R.W., Phillips R.T., Kett K.G., et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. [published erratum appears in Ann Intern Med 1988;108:646]. Ann Intern Med 108 (1988) 170-175
60. Callaham P.R., Froelicher V.F., Klein J., et al. Exercise-induced silent ischemia: age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol 14 (1989) 1175-1180
61. Fowler-Brown A., Pignone M., Pletcher M., et al. Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Service Task Force. Ann Intern Med 140 (2004) W9-24
62. McCully R.B., Roger V.L., Mahoney D.W., et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1325 patients. J Am Coll Cardiol 31 (1998) 144-149
63. Anand D.V., Lim E., Lahiri A., et al. The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 27 8 (2006) 905-912
64. Kamalesh M., Matorin R., and Sawada S. Prognostic value of negative stress echocardiographic study in diabetic patients. Am Heart J 143 (2002) 163-168
65. Elhendy A., Arruda A.M., Mahoney D.M., et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 (2001) 1551-1557
66. Patel S.J., Srivastava A., Lingam N., et al. Prognostic significance of submaximal negative dobutamine stress echocardiography: a 3-year follow-up study. Cardiol J 15 3 (2008) 237-244
67. Schinkel A.F.L., Bax J.J., Geleijnse M.L., et al. Non-invasive evaluation of ischemic heart disease: myocardial perfusion imaging or stress echocardiography. Eur Heart J 24 (2003) 789-800
68. Felsher J., Meissner M.D., Hakki A.H., et al. Exercise thallium imaging in patients with diabetes mellitus. Prognostic implications. Arch Intern Med 147 (1987) 313-317
69. Vanzetto G., Halimi S., Hammoud T., et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients: prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 22 (1999) 19-26
70. Kang X., Berman D.S., Lewin H.C., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138 (1999) 1025-1032
71. Schinkel A.F.L., Elhendy A., Van Domburg R.T., et al. Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes. Diabetes Care 25 (2002) 1637-1643
72. Zellweger M.J., Hachamovitch R., Kang X., et al. Prognostic relevance of symptoms versus evidence of coronary artery disease in diabetic patients. Eur Heart J 25 (2004) 543-550
73. Cosson E., Guimfack M., Paries J., et al. Prognosis for coronary stenoses in patients with diabetes and silent myocardial ischemia. Diabetes Care 26 (2003) 1313-1314
74. Rumberger J.A., Simons D.B., Fitzpatrick L.A., et al. Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 92 (1995) 2157-2162
75. Anand D.V., Lim E., Hopkins D., et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27 6 (2006) 713-721
76. Hendel R.C., Patel M.R., Kramer C.M., et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48 7 (2006) 1475-1497
77. Diamond G.A., Kaul S., and Shah P.K. Screen testing cardiovascular prevention in asymptomatic diabetic patients. J Am Coll Cardiol 49 19 (2007) 1915-1917